The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

29 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).EBI
Pharmacia
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.EBI
Pharmacia
Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors.EBI
Pharmacia
Polymer-assisted solution-phase (PASP) parallel synthesis of an alpha-ketothiazole library as tissue factor VIIa inhibitors.EBI
Pharmacia
3-Arylpiperidines as potentiators of existing antibacterial agents.EBI
Pharmacia
3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.EBI
Pharmacia
Synthesis and activity of selective MMP inhibitors with an aryl backbone.EBI
Pharmacia
Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.EBI
Pharmacia
Correlation of carboxylic acid pKa to protein binding and antibacterial activity of a novel class of bacterial translation inhibitors.EBI
Pharmacia
Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor.EBI
Pharmacia
Preparation of novel anthranilic acids as antibacterial agents: extensive evaluation of structural and physical properties on antibacterial activity and human serum albumin affinity.EBI
Pharmacia
Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex.EBI
Pharmacia
A catch-and-release strategy for the combinatorial synthesis of 4-acylamino-1,3-thiazoles as potential CDK5 inhibitors.EBI
Pharmacia
2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.EBI
Pharmacia
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.EBI
Pharmacia
Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity.EBI
Pharmacia
Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.EBI
Pharmacia
3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.EBI
Pharmacia
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein.EBI
Pharmacia
Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans.EBI
Pharmacia
Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase.EBI
Pharmacia
Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein.EBI
Pharmacia
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.EBI
Pharmacia
Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase.EBI
Pharmacia
Azabicyclo derivatives, process for preparation thereof and medical use thereofBDB
Shanghai Haiyan Pharmaceutical Technology
Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonistsBDB
Rugen Holdings (Cayman)
Substituted nicotinamide derivatives as kinase inhibitorsBDB
Allergan
Bromodomain inhibitorsBDB
Celgene Quanticel Research
 
Critical Difference in Chiral Recognition of N-Cbz-d/l-aspartic and -glutamic Acids by Mono- and Bis(Trimethylammonio)-β-cyclodextrinsBDB
Nagoya Institute of Technology